NAMS logo

NAMS Revenue

Annual revenue:

$45.56M+$31.47M(+223.37%)
December 31, 2024

Summary

  • As of today (May 10, 2025), NAMS annual revenue is $45.56 million, with the most recent change of +$31.47 million (+223.37%) on December 31, 2024.
  • NAMS annual revenue is now -55.63% below its all-time high of $102.69 million, reached on December 31, 2022.

Performance

1-year change

+223.37%

3-year change

-

5-year change

-

15-year change

-

NAMS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

45.65%
NAMS annual revenue is higher than 45.65% of companies in Healthcare sector

Analysts estimate

$24.83M
NAMS annual revenue is currently +83.48% higher than the consensus analysts' forecast

Range

All-time high

$102.69M
NAMS annual revenue is currently -55.63% below its historical high of $102.69 million

3-year low

$14.09M
NAMS annual revenue is currently +223.37% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NAMS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NAMS next annual earnings announcement has not yet been scheduled

OtherNAMSincome statement metrics

Annual EPS

-$2.56
NAMS annual earnings per share is -$2.56

annual net income

-$241.60M
NAMS annual net profit is -$241.60 million

annual operating profit

-$176.29M
NAMS annual operating income is -$176.29 million

Annual gross profit

-
NAMS annual gross profit value is unknown

Quarterly revenue:

$12.77M-$16.34M(-56.13%)
December 31, 2024

Summary

  • As of today (May 10, 2025), NAMS quarterly revenue is $12.77 million, with the most recent change of -$16.34 million (-56.13%) on December 31, 2024.
  • Over the past year, NAMS quarterly revenue has increased by +$11.97 million (+1490.54%).
  • NAMS quarterly revenue is now -56.13% below its all-time high of $29.11 million, reached on September 30, 2024.

Performance

3-month change

-56.13%

1-year change

+1490.54%

3-year change

-

5-year change

-

NAMS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

41.71%
NAMS quarterly revenue is higher than 41.71% of companies in Healthcare sector

Analysts estimate

$1.46M
NAMS quarterly revenue is currently +775.94% higher than the consensus analysts' forecast

Range

All-time high

$29.11M
NAMS quarterly revenue is currently -56.13% below its historical high of $29.11 million

3-year low

$803.00K
NAMS quarterly revenue is currently +1490.54% above its 3-year low

Earnings dates

Last quarterly earnings report date

Dec 31, 2024
NAMS previous earnings announcement was published on Dec 31, 2024

Next quarterly earnings report date

N/A
NAMS next earnings announcement has not yet been scheduled

OtherNAMSincome statement metrics

quarterly gross profit

-
NAMS quarterly gross profit value is unknown

quarterly operating profit

-$46.43M
NAMS quarterly operating income is -$46.43 million

quarterly net income

-$92.18M
NAMS quarterly net profit is -$92.18 million

Quarterly EPS

-$0.95
NAMS quarterly earnings per share is -$0.95

TTM revenue:

$45.56M+$11.97M(+35.63%)
December 31, 2024

Summary

  • As of today (May 10, 2025), NAMS TTM revenue is $45.56 million, with the most recent change of +$11.97 million (+35.63%) on December 31, 2024.
  • Over the past year, NAMS TTM revenue has increased by +$31.47 million (+223.37%).
  • NAMS TTM revenue is now at all-time high.

Performance

3-month change

+35.63%

1-year change

+223.37%

3-year change

-

5-year change

-

NAMS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

41.07%
NAMS TTM revenue is higher than 41.07% of companies in Healthcare sector

Analysts estimate

$45.62M
NAMS TTM revenue is currently -0.13% lower than the consensus analysts' forecast

Range

All-time high

$45.56M
NAMS TTM revenue is currently at an all-time high

3-year low

$6.86M
NAMS TTM revenue is currently +563.99% above its 3-year low

Earnings dates

Last quarterly earnings report date

Dec 31, 2024
NAMS previous earnings announcement was published on Dec 31, 2024

Next quarterly earnings report date

N/A
NAMS next earnings announcement has not yet been scheduled

OtherNAMSincome statement metrics

TTM gross profit

-
NAMS TTM gross profit value is unknown

TTM operating profit

-$176.29M
NAMS TTM operating income is -$176.29 million

TTM net income

-$241.60M
NAMS TTM net profit is -$241.60 million

TTM EPS

-$2.60
NAMS TTM earnings per share is -$2.60

NAMS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+223.4%+1490.5%+223.4%
3 y3 years---
5 y5 years---

NAMS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-55.6%+223.4%-56.1%+1490.5%at high+564.0%
5 y5-year-55.6%+223.4%-56.1%+1490.5%at high+564.0%
alltimeall time-55.6%+223.4%-56.1%+1490.5%at high+564.0%

NAMS Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$45.56M(+223.4%)
$12.77M(-56.1%)
$45.56M(+35.6%)
Sep 2024
-
$29.11M(+1177.4%)
$33.59M(+352.5%)
Jun 2024
-
$2.28M(+62.7%)
$7.42M(+8.2%)
Mar 2024
-
$1.40M(+74.5%)
$6.86M(-51.3%)
DateAnnualQuarterlyTTM
Dec 2023
$14.09M(-86.3%)
$803.00K(-72.7%)
$14.09M(+6.0%)
Sep 2023
-
$2.94M(+71.3%)
$13.29M(+28.4%)
Jun 2023
-
$1.72M(-80.1%)
$10.35M(+19.9%)
Mar 2023
-
$8.63M
$8.63M
Dec 2022
$102.69M
-
-

FAQ

  • What is NewAmsterdam Pharma Company NV annual revenue?
  • What is the all time high annual revenue for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV annual revenue year-on-year change?
  • What is NewAmsterdam Pharma Company NV quarterly revenue?
  • What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV quarterly revenue year-on-year change?
  • What is NewAmsterdam Pharma Company NV TTM revenue?
  • What is the all time high TTM revenue for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV TTM revenue year-on-year change?

What is NewAmsterdam Pharma Company NV annual revenue?

The current annual revenue of NAMS is $45.56M

What is the all time high annual revenue for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high annual revenue is $102.69M

What is NewAmsterdam Pharma Company NV annual revenue year-on-year change?

Over the past year, NAMS annual revenue has changed by +$31.47M (+223.37%)

What is NewAmsterdam Pharma Company NV quarterly revenue?

The current quarterly revenue of NAMS is $12.77M

What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high quarterly revenue is $29.11M

What is NewAmsterdam Pharma Company NV quarterly revenue year-on-year change?

Over the past year, NAMS quarterly revenue has changed by +$11.97M (+1490.54%)

What is NewAmsterdam Pharma Company NV TTM revenue?

The current TTM revenue of NAMS is $45.56M

What is the all time high TTM revenue for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high TTM revenue is $45.56M

What is NewAmsterdam Pharma Company NV TTM revenue year-on-year change?

Over the past year, NAMS TTM revenue has changed by +$31.47M (+223.37%)
On this page